Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Alpha Tau Medical's Enterprise Value is $1,229.55 Mil.
Alpha Tau Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil. Therefore, Alpha Tau Medical's EV-to-OCF for today is .
The historical rank and industry rank for Alpha Tau Medical's EV-to-OCF or its related term are showing as below:
DRTS'
s EV-to-OCF Range Over the Past 10 Years
Min: -46.08 Med: 0 Max: -46.08
Current: -46.08
During the past 7 years, the highest EV-to-OCF of Alpha Tau Medical was -46.08. The lowest was -46.08. And the median was .
DRTS's EV-to-OCF is ranked better than 91.41% of 1408
companies
in the Biotechnology industry
Industry Median: -3.66
vs DRTS: -46.08
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alpha Tau Medical (NAS:DRTS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alpha Tau Medical's PE Ratio (TTM) for today is calculated as:
Alpha Tau Medical's share price for today is $14.22.
Alpha Tau Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alpha Tau Medical EV-to-OCF Related Terms
Alpha Tau Medical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Alpha Tau Medical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Alpha Tau Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Tau Medical EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Alpha Tau Medical's EV-to-OCF falls into.
Alpha Tau Medical's current Enterprise Value is $1,229.55 Mil.
Alpha Tau Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
27GF Score
Get the complete analysis for DRTS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRTS has been successfully added to your 
